HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keena S Thomas Selected Research

Urokinase-Type Plasminogen Activator (Urokinase)

11/2003Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keena S Thomas Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
01/2021 - 04/2002
6Neoplasms (Cancer)
01/2021 - 11/2003
4Gonorrhea
04/2024 - 08/2023
2Infections
12/2023 - 08/2023
1Triple Negative Breast Neoplasms
01/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Colitis
01/2019
1Adenocarcinoma
11/2011
1Necrosis
11/2011
1Neoplasm Metastasis (Metastasis)
11/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2011
1Inflammation (Inflammations)
02/2011
1Fibrosarcoma
04/2002

Drug/Important Bio-Agent (IBA)

5Estrogen Receptor Modulators (Antiestrogen)IBA
01/2021 - 07/2006
4VaccinesIBA
04/2024 - 08/2023
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2007
3TamoxifenFDA LinkGeneric
11/2008 - 07/2006
2AntibodiesIBA
12/2023 - 08/2023
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2018 - 11/2011
1Messenger RNA (mRNA)IBA
01/2021
1Dextran SulfateIBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1N- methyl- N- (3- ((2- (2- oxo- 2,3- dihydro- 1H- indol- 5- ylamino)- 5- trifluoromethyl- pyrimidin- 4- ylamino)- methyl)- pyridin- 2- yl)- methanesulfonamideIBA
11/2011
1GemcitabineFDA Link
11/2011
1CollagenIBA
11/2011
1Growth Factor ReceptorsIBA
02/2011
1IntegrinsIBA
02/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2008
1Estrogen ReceptorsIBA
07/2007
1ErbB Receptors (EGF Receptor)IBA
07/2006
1STAT5 Transcription FactorIBA
07/2006
1Plasminogen Activators (Plasminogen Activator)IBA
04/2005
1LDL Receptors (LDL Receptor)IBA
11/2003
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2003
1Urokinase Plasminogen Activator ReceptorsIBA
11/2003
1Epidermal Growth Factor (EGF)IBA
04/2002

Therapy/Procedure

3Therapeutics
04/2024 - 11/2011
1Drug Therapy (Chemotherapy)
11/2008